AIIMS Patna Declared as Centre of Excellence for Rare Diseases by MoHFW

Date:

Share post:

 

AIIMS Patna Declared as Centre of Excellence for Rare Diseases by MoHFW

PharmaGenDRx News Bureau- 20th August,2025

10:00 AM IST

All India Institute of Medical Sciences (AIIMS), Patna was declared as a Centre of Excellence (CoE) for Rare Diseases under the National Policy for Rare Diseases (NPRD), 2021 by the Ministry of Health and Family Welfare.

Hereby AIIMS Patna becomes another CoEs to provide advanced diagnosis, prevention and treatment for patients affected by rare diseases reaffirming the Government’s commitment towards uplifting the infrastructure of tertiary healthcare. This is a promising step towards safeguarding public healthcare.

With this move AIIMS Patna is endorsed with responsibilities to continue their work towards providing sufficient aid in the nation-wide fight against rare words.

By Sharon Bose and Arundhuti Chatterjee

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...